US Bioservices Corporation
US Bioservices Corporation Part of Cencora, Inc.
- UEI
- HHDAGRZPBBZ4
- CAGE
- 3VDF2
- Primary NAICS
- 446110 Pharmacies and Drug Stores
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Cencora, Inc.
Parent
NWEGNLYTBDW4
- US Bioservices Corporation HHDAGRZPBBZ4
-
Cencora, Inc.
Parent
NWEGNLYTBDW4
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Revlimid | Veterans Integrated Service Network 12 | $10,400 | |
| Revlimid | Veterans Integrated Service Network 12 | $10,400 | |
| Revlimid | Veterans Integrated Service Network 12 | $6,862 | |
| Revlimid | Veterans Integrated Service Network 12 | $10,366 | |
| Revlimid 4 MG | Veterans Integrated Service Network 12 | $11,947 |
About US Bioservices Corporation
US Bioservices Corporation is a for-profit organization that provides pharmaceuticals to government agencies. Through its prime federal contract awards, US Bioservices Corporation has provided medications like Revlimid, Pomalyst, and Balversa to the Department of Veterans Affairs Veterans Health Administration. These medications are used to treat diseases such as multiple myeloma and bladder cancer.
US Bioservices Corporation has received over 150 prime federal contract awards from the Department of Veterans Affairs Veterans Health Administration since 2019, with no set aside designations. The contract awards have been purchase orders to provide specialty medications to various Veterans Integrated Service Networks across the country. Specific medications provided through these contract awards include Revlimid at doses from 4mg to 25mg capsules, Pomalyst 4mg capsules, and Balversa 4mg tablets. The total potential value of these awards ranges from thousands to tens of thousands of dollars per order. Additionally, in June 2020 US Bioservices Corporation received one subcontract award from the VA to deliver Balversa medication over 5 months, with a total potential value of over $60,000. Based on these contract awards, US Bioservices Corporation specializes in providing high-cost specialty pharmaceuticals to federal government customers.
Quick answers
What is US Bioservices Corporation's UEI?
US Bioservices Corporation's Unique Entity ID (UEI) in SAM.gov is HHDAGRZPBBZ4.
What is US Bioservices Corporation's CAGE code?
US Bioservices Corporation's CAGE code is 3VDF2.
What is US Bioservices Corporation's primary NAICS code?
US Bioservices Corporation's primary NAICS code is 446110 (Pharmacies and Drug Stores).
Is US Bioservices Corporation registered in SAM.gov?
US Bioservices Corporation's SAM.gov registration expired on May 27, 2023.
Who is US Bioservices Corporation's parent company?
US Bioservices Corporation is part of Cencora, Inc.
What is US Bioservices Corporation's most recent federal award?
US Bioservices Corporation's most recent federal contract award is Revlimid (36C25222P0083), from Veterans Integrated Service Network 12, on October 18, 2021.
On GovTribe
See US Bioservices Corporation's full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors